Triangle[18F]-αvβ6-BP (NCT05452005)
[18F]-αvβ6-BP trial for Metastatic Non-Small Cell Lung Cancer (NCT05452005). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for metastatic non-small cell lung cancer that has spread to the brain, in adults.
The idea: test a new PET imaging agent. Patients receive a tracer called fluorine-18 alpha-v beta-6 binding peptide by vein, then have a PET scan. The study compares it with standard scans and with tumor tissue to see how well it finds metastases. A second scan follows eight to twelve weeks later.
This phase 1 study plans 20 patients. At the University of California, Davis, Julie Sutcliffe leads it.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.